☆ 4.7 Article

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

BLOOD (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。
Editorial Material Hematology

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach COMMENT

Daniel A. Arber et al.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

添加到收藏夹
Article Hematology

DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults

Margaret A. Ferris et al.

BLOOD (2022)

添加到收藏夹
Article Hematology

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome

Tim Grob et al.

Summary: Mutant TP53 AML and MDS-EB share similar molecular characteristics and survival outcomes, suggesting that they should be considered as distinct molecular disease entities.

BLOOD (2022)

添加到收藏夹
Article Hematology

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia

Shunsuke Kimura et al.

Summary: This study identified a previously unrecognized high-risk subtype of B-ALL using transcriptome and whole-genome sequencing. The subtype is characterized by specific gene expression profile and genomic alterations caused by abnormal activation of recombination-activating genes (RAG). It is associated with high-risk clinical features.

BLOOD (2022)

添加到收藏夹
Article Hematology

Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001

Thai Hoa Tran et al.

Summary: This study found that RNA-seq technology can simultaneously identify gene rearrangements, sequence mutations, and gene expression profiles in ALL patients, which is of great importance for the diagnosis and treatment of childhood ALL.

BLOOD ADVANCES (2022)

添加到收藏夹
Article Hematology

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

Olga K. Weinberg et al.

Summary: This study evaluated the clinicopathologic features and outcomes of AML and MDS patients with complex karyotype (CK). The presence of TP53 mutation, especially multihit TP53 mutation, in the context of CK, identified a homogeneously aggressive disease, irrespective of blast count or therapy-relatedness.

BLOOD ADVANCES (2022)

添加到收藏夹
Article Pathology

Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms A Multiparameter Study of a Rare and Aggressive Entity

Shweta Bhavsar et al.

Summary: In the current classification of the World Health Organization, TdT expression in high grade/large cell B-cell lymphoma indicates B-lymphoblastic lymphoma/leukemia. However, there are reports of TdT expression in mature LBCL or following mature B-cell neoplasms. The frequency, categorization, clinicopathologic features, molecular landscape, and relationship to classic B-LBL of TdT(+) LBCL remain to be better defined. In this study, TdT expression was assessed in 258 LBCL and correlated with cytologic, phenotypic, and cytogenetic findings. Mutational analysis, review of prior biopsies, and assessment of clinical associations were performed in 6 cases with >10% TdT(+) cells. The 6 TdT(+) LBCL cases were blastoid-appearing, CD34(-), MYC+, BCL2(+), and had MYC rearrangements (R) (5/6 with BCL2 and/or BCL6-R). They had a prior TdT(-) LBCL and/or follicular lymphoma and all had an aggressive course. The mutational profiles were more like those reported in germinal center B-cell type-diffuse LBCL rather than B-LBL. The clinicopathologic and cytogenetic features of these 6 cases were similar to those found in a meta-analysis that included additional cases of TdT(+) LBCL or B-LBL following follicular lymphoma. Thus, TdT(+), CD34(-) large B-cell neoplasms with MYC rearrangements and often a double hit are rare, frequently a transformational event and aggressive but are distinct from classic B-LBL.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

添加到收藏夹
Article Hematology

Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal

Elihu Estey et al.

Summary: Including patients with 10% to 30% blasts (AML/MDS) in both AML and MDS studies would allow for testing the independent effect of blast percentage on outcome, provide more treatment options for patients, and potentially simplify the regulatory approval process.

BLOOD (2022)

添加到收藏夹
Article Hematology

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL

Marie Passet et al.

Summary: A novel subtype of B-cell acute lymphoblastic leukemia (B-ALL) characterized by CDX2 cis-deregulation and UBTF::ATXN7L3 fusion was identified in young adults, showing poor response to treatment and high risk of relapse. This subtype represents a high-risk disease entity in adults with unique genetic alterations.

BLOOD (2022)

添加到收藏夹
Article Oncology

N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)

Bradford J. Siegele et al.

Summary: The expression of the DUX4 oncoprotein detected by immunohistochemistry can serve as a surrogate for molecular detection of DUX4 fusions in B-ALL. This finding provides a new approach to subclassify B-ALL and improve understanding of its subtypes.

GENES CHROMOSOMES & CANCER (2022)

添加到收藏夹
Article Oncology

Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

Roberta Zanotti et al.

Summary: Bone marrow mastocytosis (BMM) is a provisional variant of indolent systemic mastocytosis (ISM) defined by bone marrow involvement and absence of skin lesions in the current WHO classification. BMM patients were older, predominantly male, had lower tryptase levels, lower neoplastic mast cell burden, and a higher frequency of allergic reactions triggered mainly by Hymenoptera compared to typical ISM patients. The 10-year progression-free survival of BMM was higher than that of typical ISM, and specific risk factors for progression in BMM patients were identified.

LEUKEMIA (2022)

添加到收藏夹
Article Hematology

Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm

Oriana Miltiadous et al.

Summary: FIP1L1-RARA-associated neoplasm is a rare and aggressive disease. This study presents a pediatric case with successful long-term outcome using a combination of chemotherapy, differentiating agents, and allogeneic hematopoietic stem cell transplant.

BLOOD ADVANCES (2022)

添加到收藏夹
Article Hematology

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

Satoshi Wakita et al.

Summary: Mutations of CCAAT/enhancer-binding protein alpha (CEBPAmu) significantly impact the prognosis of acute myeloid leukemia (AML). Particularly, CEBPAmu in the basic leucine zipper domain (bZIP) is strongly associated with a favorable prognosis and can serve as a potent marker for AML prognosis. This finding has implications for treatment stratification and the development of targeted therapeutic approaches in CEBPA-mutated AML.

BLOOD ADVANCES (2022)

添加到收藏夹
Letter Hematology

Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia

Marketa Zaliova et al.

HAEMATOLOGICA (2021)

添加到收藏夹
Letter Oncology

Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma

Kui Nie et al.

LEUKEMIA (2021)

添加到收藏夹
Article Oncology

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

A. Kuendgen et al.

Summary: The study shows that therapy-related myelodysplastic syndromes (t-MDS) are as heterogeneous as primary MDS, and require the same careful differentiation regarding risk. Despite less favorable clinical outcomes in t-MDS subsets compared to primary MDS, classification and prognostic scoring effectively separated t-MDS patients into different risk groups.

LEUKEMIA (2021)

添加到收藏夹
Review Pathology

Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2

Olga Pozdnyakova et al.

Summary: This study summarized cases involving myeloidlymphoid neoplasms with eosinophilia and different gene rearrangements, revealing heterogeneous disease presentations and emphasizing the importance of accurate diagnosis and classification for these rare disorders. With advancements in RNA sequencing, cryptic rearrangements and additional somatic mutations were identified, expanding our understanding of these neoplasms and improving our ability to diagnose genetically defined disorders.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹
Review Pathology

Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders Report of the 2019 Society for Hematopathology/European Association for Haematopathology Workshop

Katalin Kelemen et al.

Summary: The 2019 workshop focused on reactive eosinophilia, hypereosinophilic syndrome (HES), germline disorders with eosinophilia (GDE), and myeloid and lymphoid neoplasms associated with eosinophilia. Among 109 cases reviewed, the most frequent diagnosis was reactive eosinophilia, followed by acute leukemia. Myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDS), and therapy-related myeloid neoplasms were also discussed.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹
Article Oncology

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

Xueyan Chen et al.

Summary: sAML and MDS-EB share many similarities, including similar mutation distribution and treatment response. This suggests that they may represent different stages or lineages of the same disease.

LEUKEMIA & LYMPHOMA (2021)

添加到收藏夹
Article Multidisciplinary Sciences

Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia

Ya-Hsuan Chang et al.

Summary: Targeted sequencing of 67 genes in 64 cases of childhood T-ALL revealed a variety of genetic mutations, with high frequencies observed in NOTCH1, FAT1, FAT3, and FBXW7. Mutations in certain genes were associated with better 5-year overall survival rates for patients.

SCIENTIFIC REPORTS (2021)

添加到收藏夹
Article Hematology

Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine

Kiyomi Morita et al.

Summary: Patients with ETP-ALL/LBL have poor survival rates, while the outcomes of near-ETP ALL/LBL are similar to non-ETP ALL/LBL. Allogeneic stem cell transplant benefits ETP-ALL/LBL but not near-ETP or non-ETP ALL/LBL. The addition of nelarabine to hyper-CVAD improves survival only in non-ETP ALL.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹
Article Hematology

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study

Sabine Kayser et al.

Summary: Patients with t(8;16) AML have poor outcomes with chemotherapy, but may see substantial improvement with allogeneic hematopoietic cell transplantation performed in first complete remission (CR1).

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹
Article Hematology

Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre

Paul Deschamps et al.

Summary: MPN-U is a subtype of myeloproliferative neoplasm with diverse features, including elevated lactate dehydrogenase, thrombosis, and other characteristics. Patients require close monitoring and the development of potential prognostic scores.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹
Article Biochemistry & Molecular Biology

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree S. Sahoo et al.

Summary: This study provides insights into the genetic determinants of disease progression and clinical outcomes in individuals with myelodysplastic syndromes, particularly those with SAMD9 and SAMD9L mutations. The findings suggest that somatic genetic rescue is common in SAMD9/9L(mut) MDS, showcasing the exceptional plasticity of hematopoiesis in children.

NATURE MEDICINE (2021)

添加到收藏夹
Article Oncology

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli et al.

Summary: The study identified eight distinct subgroups of MDS based on specific genomic features, each with different prognostic outcomes. By integrating clinical and genomic variables, a novel prognostic model was developed to provide personalized survival predictions for MDS patients. This model significantly improved the accuracy of current prognostic tools and has the potential to revolutionize disease classification and prognosis in the future.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹
Letter Oncology

Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

Shinsuke Hirabayashi et al.

LEUKEMIA (2021)

添加到收藏夹
Article Pathology

Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases

Hong Fang et al.

Summary: The t(6;9)(p22;q34.1)/DEK-NUP214 is a recurrent genetic abnormality seen in 1-2% of AML patients, and rarely in MDS. This study compared 107 patients with t(6;9)/DEK-NUP214 myeloid neoplasms, revealing older age, lower white blood cell count, lower blast count, higher platelet count, and lower FLT3-ITD mutation frequency in MDS patients compared to AML patients. Survival was not significantly different between MDS and AML patients, but MDS patients showed a trend towards better survival. Multivariate analysis indicated that initial diagnosis and stem cell transplantation were prognostic factors for survival. Stem cell transplantation greatly improved survival in patients with t(6;9)/DEK-NUP214 myeloid neoplasms.

MODERN PATHOLOGY (2021)

添加到收藏夹
Article Multidisciplinary Sciences

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Alyssa L. Kennedy et al.

Summary: Research on germline genetic leukemia predisposition in Shwachman-Diamond syndrome identified early emergence of multiple hematopoietic clones with EIF6 or TP53 mutations. The germline SBDS deficiency constrains clone selection via compensatory EIF6 inactivation and maladaptive TP53 mutations, with subsequent leukemia linked to biallelic TP53 alterations. These findings offer insights into clinical surveillance strategies.

NATURE COMMUNICATIONS (2021)

添加到收藏夹
Article Allergy

CD3-CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited

Caroline Carpentier et al.

Summary: Systematically enhanced expression of T-cell surface antigens CD2, CD5, CD45RO, and CD95 by cells allows for accurate detection of CD3LCD4D L-HES. Additionally, serum CCL17/TARC levels are significantly higher in patients with L-HES compared with those with I-HES, with a threshold of 3000 pg/mL allowing for detection of all subjects with L-HES.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹
Article Oncology

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

Paola Guglielmelli et al.

Summary: The study analyzed the impact of JAK2V617F VAF on thrombosis in PV patients, finding that VAF > 50% is an independent strong predictor of future VT, but not associated with AT. The results suggest that AT and VT may require distinct management strategies.

BLOOD CANCER JOURNAL (2021)

添加到收藏夹
Letter Hematology

Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS)

Guillermo Montalban-Bravo et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹
Article Hematology

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group

Katherine Tarlock et al.

Summary: Biallelic CEBPA mutations, especially CEBPA-bZip mutations, are associated with favorable clinical outcomes in AML patients. The presence of a second CEBPA mutation does not significantly affect survival rates. Co-occurring mutations in CSF3R and GATA2 can impact the overall prognosis in CEBPA-mutated patients.

BLOOD (2021)

添加到收藏夹
Article Education, Scientific Disciplines

Blast and accelerated phase CML: room for improvement

Joan How et al.

Summary: Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of CML, significantly improving outcomes in advanced phase CML, although responses in AP and BP patients are often inadequate. Combination therapy and bone marrow transplantation may be necessary for achieving lasting remissions in these patients, and the development of novel treatment strategies remains challenging due to the small population of patients with advanced CML.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)

添加到收藏夹
Article Hematology

Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia

Nancy Beryl Janet et al.

Summary: ZNF384 gene fusions resulting from translocations with several partner genes have been described in B cell acute lymphoblastic leukemia (B-ALL) with a characteristic immunophenotype. Screening for ZNF384 translocations using immunophenotype as a tool is feasible, and EP300-ZNF384 is the most common fusion partner. Treatment response may be heterogeneous in this subset.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)

添加到收藏夹
Article Oncology

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells

Melvin E. Thomas et al.

Summary: Pediatric myelodysplastic syndromes (MDS) are associated with impaired hematopoiesis, bone marrow hypocellularity, and deletions involving chromosome 7 (monosomy 7). Mutations in SAMD9 and SAMD9L lead to alterations in cell cycle, cell proliferation, and protein translation in HSPCs, potentially causing DNA damage repair defects and apoptosis in hematopoietic cells.

LEUKEMIA (2021)

添加到收藏夹
Article Pathology

Myeloid/lymphoid neoplasms with FLT3 rearrangement

Guilin Tang et al.

Summary: Myeloid/lymphoid neoplasms with FLT3 rearrangement exhibit diverse disease presentations but share common features, including extramedullary involvement, associated eosinophilia, and multilineage involvement. Treatment options such as chemotherapy, FLT3 inhibitors, and hematopoietic stem cell transplant have shown therapeutic benefits for these patients.

MODERN PATHOLOGY (2021)

添加到收藏夹
Letter Hematology

Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations

Sa A. Wang et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹
Article Hematology

Relationship between clone metrics and clinical outcome in clonal cytopenia

Anna Galli et al.

Summary: Study on clonal cytopenia of undetermined significance (CCUS) revealed varying mutation patterns and clone metrics parameters, indicating diverse clinical expressions. Unsupervised clustering analysis based on mutation profiles identified two major clusters with different overall survival and progression risks. Clone metrics play a critical role in informing clinical decision-making for patients with clonal cytopenia.

BLOOD (2021)

添加到收藏夹
Article Hematology

CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome

Franziska Taube et al.

BLOOD (2021)

添加到收藏夹
Article Hematology

B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL

Hong Fang et al.

Summary: The research showed that BCL11B expression is associated with prognosis in patients with T-ALL/LBL and can serve as a significant marker to distinguish between ETP-ALL and non-ETP-ALL/LBL.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹
Review Oncology

Current Management of Chronic Neutrophilic Leukemia

Natasha Szuber et al.

Summary: CNL is a rare MPN characterized by oncogenic mutations in CSF3R, lacking a standard treatment approach. Allogeneic HSCT is recommended for eligible patients, while nontransplant therapies are considered for ineligible patients. However, no therapy has shown significant survival benefits, highlighting the need for further research and therapeutic options.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

添加到收藏夹
Article Oncology

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Judith M. Boer et al.

LEUKEMIA (2021)

添加到收藏夹
Review Immunology

Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity

Peter Valent et al.

Summary: Eosinophils and their mediators play a crucial role in various reactive states. Excessive eosinophils can lead to organ damage. Early therapeutic agents reducing eosinophil counts are effective in preventing irreversible damage.

SEMINARS IN IMMUNOPATHOLOGY (2021)

添加到收藏夹
Article Oncology

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

Lindsey E. Montefiori et al.

Summary: This study identified a subgroup of acute leukemias with ambiguous lineage expressing myeloid, T lymphoid, and stem cell markers, driven by aberrant allele-specific deregulation of the master transcription factor BCL11B. Chromosomal rearrangements and focal amplifications leading to superenhancer generation were identified as mechanisms behind the oncogenic deregulation of BCL11B. This ectopic expression of BCL11B in hematopoietic cells mediated by enhancer hijacking was suggested as an oncogenic driver of human lineage-ambiguous leukemia.

CANCER DISCOVERY (2021)

添加到收藏夹
Review Genetics & Heredity

T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness

Valentina Bardelli et al.

Summary: T-ALL is an immature lymphoid tumor affecting bone marrow, lymphoid organs, etc. It is a heterogeneous disease caused by multiple genetic abnormalities.

GENES (2021)

添加到收藏夹
Review Medicine, General & Internal

Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia

Ilaria Iacobucci et al.

Summary: Acute lymphoblastic leukemia (ALL) has achieved cure rates exceeding 90% in children, but remains a leading cause of cancer-related death in the young. Next generation sequencing has led to significant advances in understanding leukemogenesis and the development of novel therapeutic approaches, including mutation-specific and mutation-agnostic treatments.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹
Review Cell Biology

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms

Giuseppe G. Loscocco et al.

Summary: Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal disorders driven by mutations in JAK2, CALR, and MPL, leading to abnormal proliferation of mature cells. Mutation profiling, in combination with other variables, can be used for risk stratification and monitoring of residual disease and treatment response in MPN patients. Extensive characterization of the pathologic genome highlights selected mutations for clinical informativeness and potential impact on patient management.

CELLS (2021)

添加到收藏夹
Article Hematology

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Inge van der Werf et al.

Summary: Splicing factor (SF) mutations in patients with acute myeloid leukemia (AML) are associated with unfavorable clinical features, adverse risk factors, and shorter survival. SF3B1 mutations indicate relatively poor prognosis, especially in certain risk groups. The prognostic value of RUNX1 mutations seems to be limited to its co-occurrence with SF mutations.

BLOOD ADVANCES (2021)

添加到收藏夹
Article Hematology

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Justin Anthony Chen et al.

Summary: The resistance mechanisms to ruxolitinib in a patient with JAK2-driven hematologic malignancies may involve IKZF1 deletion and an activated B-cell receptor-like signaling phenotype.

BLOOD ADVANCES (2021)

添加到收藏夹
Review Hematology

Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment

Astrid Wintering et al.

Summary: Juvenile myelomonocytic leukemia is a complex disease with diverse clinical outcomes, ranging from spontaneous resolution to transformation to acute myeloid leukemia. Next-generation sequencing allows for more accurate molecular diagnoses, but curative treatment still relies on allogeneic hematopoietic cell transplantation for most patients. Further advances are needed to improve risk stratification algorithms for better management of the disease.

BLOOD ADVANCES (2021)

添加到收藏夹
Article Hematology

A novel class of ZNF384 aberrations in acute leukemia

Marketa Zaliova et al.

Summary: A novel class of genetic aberration affecting the ZNF384 gene has been identified in leukemia cases, mimicking the phenotype of those with canonical ZNF384 fusions. This finding suggests that some ZNF384r-like cases represent the same genetic subtype as leukemia with canonical ZNF384 fusions.

BLOOD ADVANCES (2021)

添加到收藏夹
Article Hematology

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Peter Valent et al.

Summary: Mastocytosis is a hematologic neoplasm characterized by the expansion and accumulation of neoplastic mast cells in various organs. Recent developments necessitate updates and refinements in the classification and diagnostic criteria of MC neoplasms. Adjustments in the classification of CM and SM, refinements in diagnostic criteria of SM variants, and updated criteria for MCAS were proposed for better diagnostic evaluation and prognostication.

HEMASPHERE (2021)

添加到收藏夹
Article Pathology

Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass

Amy S. Duffield et al.

Summary: Myeloid neoplasms with PDGFRA rearrangement are rare and most commonly present as chronic eosinophilic leukemia, but can sometimes manifest as acute myeloid or lymphoblastic leukemia. Patients often exhibit symptoms of hypereosinophilia, including cardiovascular and pulmonary symptoms. Increased mast cells and elevated serum tryptase levels are common features, with significant clinical overlap with systemic mastocytosis.

HEAD & NECK PATHOLOGY (2021)

添加到收藏夹
Review Oncology

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies

Valentina Cordo et al.

Summary: T-cell acute lymphoblastic leukemia (T-ALL) is a hematologic malignancy characterized by abnormal proliferation of immature thymocytes. Despite a high overall survival rate in pediatric patients, a significant number of T-ALL patients still die from relapsed or refractory disease. Novel therapies targeting recurrent genetic drivers of T-ALL are being investigated in clinical trials to improve outcomes for these patients.

BLOOD CANCER DISCOVERY (2021)

添加到收藏夹
Letter Oncology

Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing

Alexander K. Chao et al.

LEUKEMIA (2020)

添加到收藏夹
Letter Oncology

Familial myeloid malignancies with germline TET2 mutation

Nicolas Duployez et al.

LEUKEMIA (2020)

添加到收藏夹
Review Oncology

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

A. Hochhaus et al.

LEUKEMIA (2020)

添加到收藏夹
Article Hematology

Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes

Juliana Schwaab et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹
Article Hematology

Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia

Robert P. Hasserjian et al.

BLOOD (2020)

添加到收藏夹
Article Hematology

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

Luca Malcovati et al.

BLOOD (2020)

添加到收藏夹
Article Hematology

Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study

Kathryn Foucar et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)

添加到收藏夹
Review Hematology

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes

Sushree S. Sahoo et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)

添加到收藏夹
Article Hematology

Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms

Laura Palomo et al.

BLOOD (2020)

添加到收藏夹
Article Oncology

Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol

Mareike Jung et al.

GENES CHROMOSOMES & CANCER (2020)

添加到收藏夹
Article Hematology

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results

Claude Gardin et al.

BLOOD ADVANCES (2020)

添加到收藏夹
Article Oncology

Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia

Zhining Chen et al.

LEUKEMIA & LYMPHOMA (2020)

添加到收藏夹
Article Hematology

Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes

Yasunobu Nagata et al.

BLOOD (2020)

添加到收藏夹
Article Biochemistry & Molecular Biology

Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard et al.

NATURE MEDICINE (2020)

添加到收藏夹
Article Oncology

Chronic Myeloid Leukemia, Version 2.2021

Michael W. Deininger et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

添加到收藏夹
Letter Oncology

Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version

Jiwon Yun et al.

LEUKEMIA & LYMPHOMA (2020)

添加到收藏夹
Review Biochemistry & Molecular Biology

NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?

Fabio Forghieri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹
Article Medicine, General & Internal

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

David B. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹
Article Hematology

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features

Xavier Calvo et al.

BLOOD ADVANCES (2020)

添加到收藏夹
Article Hematology

Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies

Amy M. Trottier et al.

BLOOD ADVANCES (2020)

添加到收藏夹
Article Hematology

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion

Kentaro Ohki et al.

HAEMATOLOGICA (2019)

添加到收藏夹
Review Hematology

Genetic predisposition to MDS: clinical features and clonal evolution

Alyssa L. Kennedy et al.

BLOOD (2019)

添加到收藏夹
Review Hematology

Juvenile myelomonocytic leukemia: who's the driver at the wheel?

Charlotte M. Niemeyer et al.

BLOOD (2019)

添加到收藏夹
Article Hematology

Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum

Alain Sarasin et al.

BLOOD (2019)

添加到收藏夹
Article Hematology

CD371 cell surface expression: A unique feature of DUX4-rearranged acute lymphoblastic leukemia

Dagmar Schinnerl et al.

HAEMATOLOGICA (2019)

添加到收藏夹
Letter Hematology

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

Brice Mouttet et al.

HAEMATOLOGICA (2019)

添加到收藏夹
Letter Hematology

NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2

Femke M. Hormann et al.

HAEMATOLOGICA (2019)

添加到收藏夹
Article Oncology

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

Lorenz Bastian et al.

LEUKEMIA (2019)

添加到收藏夹
Article Hematology

ERCC6L2 defines a novel entity within inherited acute myeloid leukemia

Suvi P. M. Douglas et al.

BLOOD (2019)

添加到收藏夹
Review Hematology

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

Peter Valent et al.

HAEMATOLOGICA (2019)

添加到收藏夹
Article Oncology

Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup

Laura N. Toth et al.

LEUKEMIA & LYMPHOMA (2019)

添加到收藏夹
Article Hematology

Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin

Michael Lauseker et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

添加到收藏夹
Letter Hematology

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Ilaria Tanasi et al.

BLOOD (2019)

添加到收藏夹
Article Oncology

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

Tiziano Barbui et al.

BLOOD CANCER JOURNAL (2019)

添加到收藏夹
Letter Hematology

Noonan syndrome-associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making

Mattias Hofmans et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

添加到收藏夹
Article Hematology

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome

Marie Passet et al.

BLOOD (2019)

添加到收藏夹
Article Hematology

The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis

Catherine Cargo et al.

BLOOD (2019)

添加到收藏夹
Article Oncology

Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia

Nicholas C. P. Cross et al.

LEUKEMIA (2019)

添加到收藏夹
Article Oncology

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

Detlef Haase et al.

LEUKEMIA (2019)

添加到收藏夹
Article Pathology

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

Guilin Tang et al.

MODERN PATHOLOGY (2019)

添加到收藏夹
Article Genetics & Heredity

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Zhaohui Gu et al.

NATURE GENETICS (2019)

添加到收藏夹
Article Pathology

Bone Marrow Morphology Associated With Germline RUNX1 Mutations in Patients With Familial Platelet Disorder With Associated Myeloid Malignancy

Karen M. Chisholm et al.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2019)

添加到收藏夹
Article Medicine, Research & Experimental

Hematologic malignancies and Li-Fraumeni syndrome

Mahesh Swaminathan et al.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)

添加到收藏夹
Article Hematology

Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms

Sanjay S. Patel et al.

BLOOD ADVANCES (2019)

添加到收藏夹
Article Hematology

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

Guillermo Montalban-Bravo et al.

BLOOD ADVANCES (2019)

添加到收藏夹
Article Multidisciplinary Sciences

Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans

Eevi Kaasinen et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹
Letter Hematology

MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies

Tim Ripperger et al.

HAEMATOLOGICA (2018)

添加到收藏夹
Article Hematology

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Giovanni Cazzaniga et al.

HAEMATOLOGICA (2018)

添加到收藏夹
Article Multidisciplinary Sciences

Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia

Bing Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹
Letter Hematology

MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies

Tim Ripperger et al.

HAEMATOLOGICA (2018)

添加到收藏夹
Article Hematology

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Giovanni Cazzaniga et al.

HAEMATOLOGICA (2018)

添加到收藏夹
Article Pathology

A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow A Single Institutional Experience

Hong Fang et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2018)

添加到收藏夹
Article Hematology

Integrated molecular profiling of juvenile myelomonocytic leukemia

Norihiro Murakami et al.

BLOOD (2018)

添加到收藏夹
Letter Hematology

ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition

Kathryn G. Roberts et al.

BLOOD (2018)

添加到收藏夹
Article Oncology

Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia

Michelle L. Churchman et al.

CANCER CELL (2018)

添加到收藏夹
Article Pathology

FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report

Koping Chang et al.

HUMAN PATHOLOGY (2018)

添加到收藏夹
Article Oncology

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children

Maoxiang Qian et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹
Letter Oncology

The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS

Blanca Xicoy et al.

LEUKEMIA RESEARCH (2018)

添加到收藏夹
Review Oncology

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

Tiziano Barbui et al.

BLOOD CANCER JOURNAL (2018)

添加到收藏夹
Letter Oncology

CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival

Natasha Szuber et al.

BLOOD CANCER JOURNAL (2018)

添加到收藏夹
Article Hematology

MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML

Mathijs A. Sanders et al.

BLOOD (2018)

添加到收藏夹
Letter Hematology

Donor-derived MDS/AML in families with germline GATA2 mutation

Pallavi Galera et al.

BLOOD (2018)

添加到收藏夹
Article Multidisciplinary Sciences

The genetic basis and cell of origin of mixed phenotype acute leukaemia

Thomas B. Alexander et al.

NATURE (2018)

添加到收藏夹
Article Oncology

Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors

Wei Xie et al.

CANCER GENETICS (2018)

添加到收藏夹
Article Hematology

IG-MYC plus neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Rabea Wagener et al.

BLOOD (2018)

添加到收藏夹
Article Oncology

Bone Marrow Core Biopsy in 508 Consecutive Patients With Chronic Myeloid Leukemia: Assessment of Potential Value

Juliana E. Hidalgo-Lopez et al.

CANCER (2018)

添加到收藏夹
Article Multidisciplinary Sciences

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases

Jian-Feng Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹
Article Oncology

Prefibrotic myelofibrosis: treatment algorithm 2018

Guido Finazzi et al.

BLOOD CANCER JOURNAL (2018)

添加到收藏夹
Article Hematology

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories

Sanam Loghavi et al.

BLOOD ADVANCES (2018)

添加到收藏夹
Review Hematology

Genomics of chronic neutrophilic leukemia

Julia E. Maxson et al.

BLOOD (2017)

添加到收藏夹
Review Hematology

Myeloid neoplasms with eosinophilia

Andreas Reiter et al.

BLOOD (2017)

添加到收藏夹
Review Hematology

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

Peter Valent et al.

BLOOD (2017)

添加到收藏夹
Article Hematology

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype

Shinsuke Hirabayashi et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Letter Oncology

A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?

E. Troadec et al.

LEUKEMIA (2017)

添加到收藏夹
Letter Oncology

Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants

V. Pastor et al.

LEUKEMIA (2017)

添加到收藏夹
Article Pathology

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

Umberto Gianelli et al.

MODERN PATHOLOGY (2017)

添加到收藏夹
Article Hematology

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype

Shinsuke Hirabayashi et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Article Oncology

ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype

Marketa Zaliova et al.

GENES CHROMOSOMES & CANCER (2017)

添加到收藏夹
Letter Hematology

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

Ana Valencia-Martinez et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Article Hematology

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome

Sa A. Wang et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Article Hematology

Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases

C. Zaninetti et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

添加到收藏夹
Article Oncology

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

Koichi Takahashi et al.

LANCET ONCOLOGY (2017)

添加到收藏夹
Letter Oncology

Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation

S. Kobayashi et al.

LEUKEMIA (2017)

添加到收藏夹
Letter Oncology

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia

M. Jawhar et al.

LEUKEMIA (2017)

添加到收藏夹
Article Pathology

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia

Julia T. Geyer et al.

MODERN PATHOLOGY (2017)

添加到收藏夹
Article Genetics & Heredity

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

Yu Liu et al.

NATURE GENETICS (2017)

添加到收藏夹
Article Oncology

Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7

Katrina O'Halloran et al.

PEDIATRIC BLOOD & CANCER (2017)

添加到收藏夹
Article Multidisciplinary Sciences

The genomic landscape of pediatric myelodysplastic syndromes

Jason R. Schwartz et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹
Article Oncology

A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia

Alfred Chung et al.

CANCER GENETICS (2017)

添加到收藏夹
Article Oncology

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

Elisa Rumi et al.

ONCOTARGET (2017)

添加到收藏夹
Article Oncology

Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia

Yuan Ouyang et al.

ONCOTARGET (2017)

添加到收藏夹
Article Oncology

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Peter Valent et al.

ONCOTARGET (2017)

添加到收藏夹
Article Medicine, Research & Experimental

Inherited TP53 Mutations and the Li-Fraumeni Syndrome

Tanya Guha et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

添加到收藏夹
Review Oncology

Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia

Kim-Hien T. Dao et al.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)

添加到收藏夹
Letter Hematology

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia

Ana Valencia-Martinez et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Article Hematology

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome

Sa A. Wang et al.

HAEMATOLOGICA (2017)

添加到收藏夹
Article Multidisciplinary Sciences

Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing

Jee-Soo Lee et al.

PLOS ONE (2017)

添加到收藏夹
Review Hematology

Philadelphia chromosome-like acute lymphoblastic leukemia

Sarah K. Tasian et al.

BLOOD (2017)

添加到收藏夹
Letter Hematology

Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance

Rangit Vallapureddy et al.

AMERICAN JOURNAL OF HEMATOLOGY (2017)

添加到收藏夹
Article Hematology

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

Georg Jeryczynski et al.

AMERICAN JOURNAL OF HEMATOLOGY (2017)

添加到收藏夹
Article Hematology

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML

Dorothee Selimoglu-Buet et al.

BLOOD (2017)

添加到收藏夹
Article Pathology

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

Elizabeth Margolskee et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)

添加到收藏夹
Article Hematology

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis

Paola Guglielmelli et al.

BLOOD (2017)

添加到收藏夹
Article Hematology

Clinical significance of somatic mutation in unexplained blood cytopenia

Luca Malcovati et al.

BLOOD (2017)

添加到收藏夹
Article Hematology

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Lenka Hovorkova et al.

BLOOD (2017)

添加到收藏夹
Review Hematology

The genetics and molecular biology of T-ALL

Tiziana Girardi et al.

BLOOD (2017)

添加到收藏夹
Review Genetics & Heredity

Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition

Christopher Cunniff et al.

MOLECULAR SYNDROMOLOGY (2017)

添加到收藏夹
Article Hematology

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

Marcin W. Wlodarski et al.

BLOOD (2016)

添加到收藏夹
Article Oncology

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

H. Gisslinger et al.

LEUKEMIA (2016)

添加到收藏夹
Article Hematology

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution

Yoshimasa Kamoda et al.

ACTA HAEMATOLOGICA (2016)

添加到收藏夹
Article Hematology

Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Courtney D. DiNardo et al.

AMERICAN JOURNAL OF HEMATOLOGY (2016)

添加到收藏夹
Letter Hematology

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Peter L. Greenberg et al.

BLOOD (2016)

添加到收藏夹
Article Hematology

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Chiara Elena et al.

BLOOD (2016)

添加到收藏夹
Review Hematology

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber et al.

BLOOD (2016)

添加到收藏夹
Review Hematology

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Steven H. Swerdlow et al.

BLOOD (2016)

添加到收藏夹
Article Hematology

The current perspective of low-grade myelodysplastic syndrome in children

Daisuke Hasegawa

INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)

添加到收藏夹
Letter Oncology

Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing

A. Pardanani et al.

LEUKEMIA (2016)

添加到收藏夹
Article Oncology

Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges

Laura Moench et al.

LEUKEMIA & LYMPHOMA (2016)

添加到收藏夹
Article Pathology

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

Sa A. Wang et al.

MODERN PATHOLOGY (2016)

添加到收藏夹
Article Genetics & Heredity

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

Takahiko Yasuda et al.

NATURE GENETICS (2016)

添加到收藏夹
Article Genetics & Heredity

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia

Jinghui Zhang et al.

NATURE GENETICS (2016)

添加到收藏夹
Article Medicine, General & Internal

Genomic Classification and Prognosis in Acute Myeloid Leukemia

Elli Papaemmanuil et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹
Article Oncology

Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion

Mary Shago et al.

PEDIATRIC BLOOD & CANCER (2016)

添加到收藏夹
Article Multidisciplinary Sciences

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

Henrik Lilljebjorn et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹
Article Multidisciplinary Sciences

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Zhaohui Gu et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹
Article Hematology

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Katherine R. Calvo et al.

BLOOD (2015)

添加到收藏夹
Article Oncology

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

Gaelle Bougeard et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹
Article Genetics & Heredity

Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort

N. Lavoine et al.

JOURNAL OF MEDICAL GENETICS (2015)

添加到收藏夹
Article Pathology

Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia

Olga K. Weinberg et al.

MODERN PATHOLOGY (2015)

添加到收藏夹
Article Genetics & Heredity

Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

Ute Fischer et al.

NATURE GENETICS (2015)

添加到收藏夹
Article Medicine, General & Internal

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia

T. Yoshizato et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹
Article Hematology

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

Patricia Font et al.

ANNALS OF HEMATOLOGY (2015)

添加到收藏夹
Article Hematology

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley et al.

BLOOD (2015)

添加到收藏夹
Article Oncology

Predicting Early Blast Transformation in Chronic-Phase Chronic Myeloid Leukemia: Is Immunophenotyping the Missing Link?

Fuad El Rassi et al.

CANCER (2015)

添加到收藏夹
Article Hematology

Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity

Michael Y. Zhang et al.

HAEMATOLOGICA (2015)

添加到收藏夹
Article Pathology

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

Robert S. Ohgami et al.

MODERN PATHOLOGY (2015)

添加到收藏夹
Article Oncology

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

M. G. Della Porta et al.

LEUKEMIA (2015)

添加到收藏夹
Review Oncology

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal

P. Valent et al.

ANNALS OF ONCOLOGY (2014)

添加到收藏夹
Article Hematology

Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling

Erdogan Taskesen et al.

BLOOD (2014)

添加到收藏夹
Article Hematology

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms

Sa A. Wang et al.

BLOOD (2014)

添加到收藏夹
Article Hematology

Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification

Daisuke Hasegawa et al.

BRITISH JOURNAL OF HAEMATOLOGY (2014)

添加到收藏夹
Article Hematology

Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood

Ayami Yoshimi et al.

HAEMATOLOGICA (2014)

添加到收藏夹
Article Hematology

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study

Heesun J. Rogers et al.

HAEMATOLOGICA (2014)

添加到收藏夹
Article Hematology

Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan

Koichi Moriwaki et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)

添加到收藏夹
Article Allergy

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

Ivan Alvarez-Twose et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

添加到收藏夹
Review Genetics & Heredity

Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium Care for CMMR-D (C4CMMR-D)

H. F. A. Vasen et al.

JOURNAL OF MEDICAL GENETICS (2014)

添加到收藏夹
Article Genetics & Heredity

Juvenile myelomonocytic leukaemia and Noonan syndrome

Marion Strullu et al.

JOURNAL OF MEDICAL GENETICS (2014)

添加到收藏夹
Letter Oncology

Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c. 547G>A

F. Auer et al.

LEUKEMIA (2014)

添加到收藏夹
Article Oncology

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status

M. Schmidt et al.

LEUKEMIA (2014)

添加到收藏夹
Article Oncology

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

M. M. Patnaik et al.

LEUKEMIA (2014)

添加到收藏夹
Article Oncology

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias

E. Schuler et al.

LEUKEMIA RESEARCH (2014)

添加到收藏夹
Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹
Article Hematology

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

Sa A. Wang et al.

AMERICAN JOURNAL OF HEMATOLOGY (2013)

添加到收藏夹
Article Hematology

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Esperanza Such et al.

BLOOD (2013)

添加到收藏夹
Letter Hematology

High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood

Ayami Yoshimi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

添加到收藏夹
Article Oncology

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphael Itzykson et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹
Article Pathology

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease

Leonardo Boiocchi et al.

MODERN PATHOLOGY (2013)

添加到收藏夹
Article Oncology

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

A. Pardanani et al.

LEUKEMIA (2013)

添加到收藏夹
Article Oncology

Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

J. Broseus et al.

LEUKEMIA (2013)

添加到收藏夹
Article Oncology

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

J. V. Jovanovic et al.

LEUKEMIA (2013)

添加到收藏夹
Article Genetics & Heredity

The genomic landscape of hypodiploid acute lymphoblastic leukemia

Linda Holmfeldt et al.

NATURE GENETICS (2013)

添加到收藏夹
Article Genetics & Heredity

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

Sohela Shah et al.

NATURE GENETICS (2013)

添加到收藏夹
Article Oncology

WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update

Hans Michael Kvasnicka

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)

添加到收藏夹
Article Genetics & Heredity

Exome Sequencing Identifies Autosomal-Dominant SRP72 Mutations Associated with Familial Aplasia and Myelodysplasia

Michael Kirwan et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

添加到收藏夹
Article Hematology

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

Frank G. Rueckner et al.

BLOOD (2012)

添加到收藏夹
Article Hematology

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

Manja Meggendorfer et al.

BLOOD (2012)

添加到收藏夹
Article Hematology

Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity

Ulrike Bacher et al.

BLOOD (2012)

添加到收藏夹
Article Hematology

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg et al.

BLOOD (2012)

添加到收藏夹
Article Hematology

PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies

Francois P. Duhoux et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

添加到收藏夹
Article Cell Biology

Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria

Irith Baumann et al.

HISTOPATHOLOGY (2012)

添加到收藏夹
Article Pathology

Myelodysplastic Syndrome With inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Has a High Risk for Progression to Acute Myeloid Leukemia

Wei Cui et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)

添加到收藏夹
Article Hematology

First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation

Haowen Xiao et al.

BLOOD (2011)

添加到收藏夹
Article Hematology

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Juergen Thiele et al.

BLOOD (2011)

添加到收藏夹
Article Hematology

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Elias Campo et al.

BLOOD (2011)

添加到收藏夹
Article Hematology

Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia

Thomas Ernst et al.

BRITISH JOURNAL OF HAEMATOLOGY (2011)

添加到收藏夹
Article Oncology

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

Tiziano Barbui et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

添加到收藏夹
Letter Oncology

The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML

C. Haferlach et al.

LEUKEMIA (2011)

添加到收藏夹
Article Hematology

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)

Brunangelo Falini et al.

BLOOD (2010)

添加到收藏夹
Letter Hematology

The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status

Marina Diaz-Beya et al.

BLOOD (2010)

添加到收藏夹
Letter Hematology

Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia - do we have to screen?

Axel Karow et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)

添加到收藏夹
Article Oncology

Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)

Karl Sotlar et al.

JOURNAL OF PATHOLOGY (2010)

添加到收藏夹
Letter Oncology

ALK fusion genes in children with atypical myeloproliferative leukemia

S. Roettgers et al.

LEUKEMIA (2010)

添加到收藏夹
Article Hematology

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

James W. Vardiman et al.

BLOOD (2009)

添加到收藏夹
Article Hematology

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy

Carolyn J. Owen et al.

BLOOD (2008)

添加到收藏夹
Review Oncology

Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias

J. Gotlib et al.

LEUKEMIA (2008)

添加到收藏夹
Review Oncology

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features

A. Orazi et al.

LEUKEMIA (2008)

添加到收藏夹
Article Oncology

Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm

Falko Fend et al.

LEUKEMIA RESEARCH (2008)

添加到收藏夹
Letter Oncology

Fusion of FIP1L1 and RARA as a result of a novel t(4;17)(q12;q21) in a case of juvenile myelomonocytic leukemia

A. Buijs et al.

LEUKEMIA (2007)

添加到收藏夹
Article Oncology

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

A. Matsuda et al.

LEUKEMIA (2007)

添加到收藏夹
Article Pathology

Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de Novo disease

Sa A. Wang et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)

添加到收藏夹
Article Oncology

Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL):: Detection of FIP1L1/PDGFRα, classification by WHO criteria, and response to therapy with imatinib

Stefan Florian et al.

LEUKEMIA RESEARCH (2006)

添加到收藏夹
Article Oncology

Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal

JE Cortes et al.

CANCER (2006)

添加到收藏夹
Article Pathology

Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case

S Heiss et al.

HUMAN PATHOLOGY (2005)

添加到收藏夹
Article Hematology

FIP1L1-PDGFRA fusion:: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

A Pardanani et al.

BLOOD (2004)

添加到收藏夹
Article Hematology

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

A Pardanani et al.

BLOOD (2003)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.